Stay updated with breaking news from Nanometrix Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Calgary, Alberta--(Newsfile Corp. - December 15, 2022) - NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) ("we", "our", the "Company" or "NurExone"), a biopharmaceutical company developing biologically-guided
(2022-12-15 | TSXV:NRX) NurExone Issues Annual Shareholder Letter
(2022-11-24 | TSXV:NRX) NurExone Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Calgary, Alberta--(Newsfile Corp. - November 24, 2022) - NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (the "Company" or "NurExone"), a biopharmaceutical company developing biologically-guided exosome